ATE463259T1 - Nasenschleimhaut haftende matrix - Google Patents

Nasenschleimhaut haftende matrix

Info

Publication number
ATE463259T1
ATE463259T1 AT00991043T AT00991043T ATE463259T1 AT E463259 T1 ATE463259 T1 AT E463259T1 AT 00991043 T AT00991043 T AT 00991043T AT 00991043 T AT00991043 T AT 00991043T AT E463259 T1 ATE463259 T1 AT E463259T1
Authority
AT
Austria
Prior art keywords
brain
mucous membrane
nasal mucous
matrix adhesive
drug
Prior art date
Application number
AT00991043T
Other languages
English (en)
Inventor
Yoko Akiyama
Naoki Nagahara
Hiroto Bando
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Application granted granted Critical
Publication of ATE463259T1 publication Critical patent/ATE463259T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
AT00991043T 1999-08-26 2000-08-25 Nasenschleimhaut haftende matrix ATE463259T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24016299 1999-08-26
PCT/JP2000/005739 WO2001015735A1 (fr) 1999-08-26 2000-08-25 Matrice adherant a la muqueuse nasale

Publications (1)

Publication Number Publication Date
ATE463259T1 true ATE463259T1 (de) 2010-04-15

Family

ID=17055427

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00991043T ATE463259T1 (de) 1999-08-26 2000-08-25 Nasenschleimhaut haftende matrix

Country Status (7)

Country Link
US (1) US6663883B1 (de)
EP (1) EP1206943B1 (de)
AT (1) ATE463259T1 (de)
AU (1) AU6730400A (de)
CA (1) CA2381860C (de)
DE (1) DE60044134D1 (de)
WO (1) WO2001015735A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9707934D0 (en) * 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
EA006384B1 (ru) * 2000-07-31 2005-12-29 Нюкомед Данмарк А/С Композиция фентанила для интраназального введения
US8815793B2 (en) 2001-07-20 2014-08-26 Northwestern University Polymeric compositions and related methods of use
US7858679B2 (en) 2001-07-20 2010-12-28 Northwestern University Polymeric compositions and related methods of use
US7618937B2 (en) 2001-07-20 2009-11-17 Northwestern University Peptidomimetic polymers for antifouling surfaces
DE60239634D1 (de) * 2001-12-10 2011-05-12 Novartis Ag Verfahren zur behandlung von psychosen und schizophrenie auf der basis eines polymorphismus im cntf gen
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
US8911831B2 (en) 2002-07-19 2014-12-16 Northwestern University Surface independent, surface-modifying, multifunctional coatings and applications thereof
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
US20070068517A1 (en) * 2005-09-29 2007-03-29 Crohn Steven S Composition for use with artificial airway devices
US20080319083A1 (en) * 2006-01-27 2008-12-25 Asahi Kasei Pharma Corporation Medicine for transnasal administration
US7732539B2 (en) 2006-02-16 2010-06-08 National Science Foundation Modified acrylic block copolymers for hydrogels and pressure sensitive wet adhesives
US20090306167A1 (en) * 2006-03-16 2009-12-10 Edwin Cohen Pharmaceutical Compositions for Intranasal Administration Comprising a Melatonin Receptor Agonist, Uses Thereof
US8563117B2 (en) 2006-08-04 2013-10-22 Phillip B. Messersmith Biomimetic modular adhesive complex: materials, methods and applications therefore
US7622533B2 (en) 2006-08-04 2009-11-24 Nerites Corporation Biomimetic compounds and synthetic methods therefor
EP1891946A1 (de) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Transmukosale Verabreichung von 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinon
US8383092B2 (en) 2007-02-16 2013-02-26 Knc Ner Acquisition Sub, Inc. Bioadhesive constructs
US8673286B2 (en) 2007-04-09 2014-03-18 Northwestern University DOPA-functionalized, branched, poly(aklylene oxide) adhesives
WO2010008746A1 (en) * 2008-06-19 2010-01-21 Takeda Pharmaceutical Company Limited Pharmaceutical compositions and methods for treating age-related macular degeneration with melatonin analogues
WO2012064821A2 (en) 2010-11-09 2012-05-18 Knc Ner Acquisition Sub, Inc. Adhesive compounds and methods use for hernia repair
CN103429223A (zh) * 2011-01-17 2013-12-04 武田药品工业株式会社 口腔分散片
WO2013054582A1 (en) 2011-10-14 2013-04-18 Takeda Pharmaceutical Company Limited Orally dispersible tablet
JP7487443B2 (ja) * 2019-09-30 2024-05-21 ハウスウェルネスフーズ株式会社 粘膜上皮適用組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6185332A (ja) * 1984-10-04 1986-04-30 Kao Corp 経粘膜吸収促進剤及びこれを含有する経粘膜投与用製剤
US5071875A (en) 1989-09-25 1991-12-10 Northwestern University Substituted 2-amidotetralins as melatonin agonists and antagonists
FR2658818B1 (fr) 1990-02-27 1993-12-31 Adir Cie Nouveaux derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
TW209174B (de) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
IT1250421B (it) 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
IT1254995B (it) 1992-06-24 1995-10-11 Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
US5744155A (en) 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
EP0642797B1 (de) 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulierung enthaltend einen antibakteriellen und einen Antiulcus Wirkstoff
FR2712807B1 (fr) 1993-11-24 1996-02-23 Vetoquinol Sa Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
WO1998042311A1 (en) * 1997-03-25 1998-10-01 Takeda Chemical Industries, Ltd. Gastrointestinal mucosa-adherent pharmaceutical composition
AU6422798A (en) 1997-03-25 1998-10-20 Takeda Chemical Industries Ltd. Stabilized urease inhibitor

Also Published As

Publication number Publication date
EP1206943A1 (de) 2002-05-22
US6663883B1 (en) 2003-12-16
EP1206943A4 (de) 2004-06-23
DE60044134D1 (de) 2010-05-20
AU6730400A (en) 2001-03-26
EP1206943B1 (de) 2010-04-07
CA2381860C (en) 2009-11-24
WO2001015735A1 (fr) 2001-03-08
CA2381860A1 (en) 2001-03-08

Similar Documents

Publication Publication Date Title
ATE463259T1 (de) Nasenschleimhaut haftende matrix
ATE315420T1 (de) Elektrodenleitung zur stimulation von wirbelsaülen
BR0316969A (pt) Tratamento de mal de huntington com epa
EP1181948A3 (de) Katheterleitung zur Implantation in dem Intrathekalen Raum
ATE517615T1 (de) Schmerzstillendes und entzündungshemmendes pflaster zur lokalen anwendung
CO4770978A1 (es) Empleo de epinastina para el tratamiento de dolores
FI980822A0 (fi) Farmaseuttinen koostumus vaikuttavan aineen iho- tai limakalvopintaan tai iho- tai limakalvopinnan läpi
TR200101307T2 (tr) Antranilik asit amidler ve ilaç olarak kullanılmaları.
DE60029566D1 (de) In-vitro herstellung von transplantierbarem knorpelgewebe
DK0621032T3 (da) Lægemiddelform med reguleret afgivelse
WO2003039620A3 (en) Integrated transdermal drug delivery system
BR0215404A (pt) processo e dispositivo para reduzir dosagem terapêutica
NO20013958L (no) Legemiddel for behandling av höyt blodtrykk
WO2007047198A3 (en) Method and apparatus for sublingual application of light to blood
WO2004041127A3 (en) Medical devices including a magnetically activatable body or portion
PL372666A1 (en) Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation
AU2001258395A1 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
DE69625918D1 (de) Lang wirksames mittel zur rektalen verabreichung
DE69608122D1 (de) Mikroverkapselte dna zur impfung und gentherapie
AU2001240674A1 (en) Dihydropyrimidine-5-carboxylic acid esters and use thereof as medicaments against viral diseases
AU2003282065A1 (en) Nasal stick for the applocation of medicaments and skin care substances
DE60107888D1 (de) Beta-Interferon zur Behandlung von Immunerkrankungen
ATE336987T1 (de) Gelzubereitung enthaltend einen gelösten oder suspendierten wirkstoff,insbesondere zur anwendung auf einer schleimhaut und herstellungsverfahren
DE60043648D1 (de) Medikamente zur behandlung von periodontalen erkrankungen
WO2007040702A3 (en) Method and apparatus for sublingual application of light to blood

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties